Literature DB >> 33635633

Acute Dose-Dependent Neuroprotective Effects of Poly(pro-17β-estradiol) in a Mouse Model of Spinal Contusion Injury.

Manoj K Gottipati1,2, Samuel A T Ellman3, Devan L Puhl1, Zhen Guan2, Phillip G Popovich2, Edmund F Palermo3, Ryan J Gilbert1.   

Abstract

17β-Estradiol (E2) confers neuroprotection in preclinical models of spinal cord injury when administered systemically. The goal of this study was to apply E2 locally to the injured spinal cord for a sustained duration using poly(pro-E2) film biomaterials. Following contusive spinal cord injury in adult male mice, poly(pro-E2) films were implanted subdurally and neuroprotection was assessed using immunohistochemistry 7 days after injury and implantation. In these studies, poly(pro-E2) films modestly improved neuroprotection without affecting the inflammatory response when compared to the injured controls. To increase the E2 dose released, bolus-releasing poly(pro-E2) films were fabricated by incorporating unbound E2 into the poly(pro-E2) films. However, compared to the injured controls, bolus-releasing poly(pro-E2) films did not significantly enhance neuroprotection or limit inflammation at either 7 or 21 days post-injury. Future work will focus on developing poly(pro-E2) biomaterials capable of more precisely releasing therapeutic doses of E2.

Entities:  

Keywords:  Estrogen; inflammation; neuroprotection; poly(prodrug); spinal cord injury

Mesh:

Substances:

Year:  2021        PMID: 33635633      PMCID: PMC8785687          DOI: 10.1021/acschemneuro.0c00798

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  23 in total

Review 1.  Regeneration beyond the glial scar.

Authors:  Jerry Silver; Jared H Miller
Journal:  Nat Rev Neurosci       Date:  2004-02       Impact factor: 34.870

Review 2.  Estrogen as a neuroprotective agent in the treatment of spinal cord injury.

Authors:  Eric Anthony Sribnick; James Michael Wingrave; Deborah Denise Matzelle; Swapan Kumar Ray; Naren Lal Banik
Journal:  Ann N Y Acad Sci       Date:  2003-05       Impact factor: 5.691

3.  Statewide investigation of medically attended adverse health conditions of persons with spinal cord injury.

Authors:  Elisabeth Pickelsimer; Eric J Shiroma; Dulaney A Wilson
Journal:  J Spinal Cord Med       Date:  2010       Impact factor: 1.985

4.  Systemic administration of 17beta-estradiol reduces apoptotic cell death and improves functional recovery following traumatic spinal cord injury in rats.

Authors:  Tae Y Yune; Sun J Kim; Sang M Lee; Young K Lee; Young J Oh; Young C Kim; George J Markelonis; Tae H Oh
Journal:  J Neurotrauma       Date:  2004-03       Impact factor: 5.269

5.  Estradiol protects mesencephalic dopaminergic neurons from oxidative stress-induced neuronal death.

Authors:  H Sawada; M Ibi; T Kihara; M Urushitani; A Akaike; S Shimohama
Journal:  J Neurosci Res       Date:  1998-12-01       Impact factor: 4.164

Review 6.  Estradiol and neurodegenerative oxidative stress.

Authors:  Jon Nilsen
Journal:  Front Neuroendocrinol       Date:  2008-01-11       Impact factor: 8.606

7.  17beta-estradiol attenuates glutamate-induced apoptosis and preserves electrophysiologic function in primary cortical neurons.

Authors:  Eric Anthony Sribnick; Swapan Kumar Ray; Mark Walter Nowak; Li Li; Naren Lal Banik
Journal:  J Neurosci Res       Date:  2004-06-01       Impact factor: 4.164

Review 8.  Donald Munro Lecture. Spinal cord injury--past, present, and future.

Authors:  William H Donovan
Journal:  J Spinal Cord Med       Date:  2007       Impact factor: 1.985

Review 9.  Spinal cord injury: a review of current therapy, future treatments, and basic science frontiers.

Authors:  Abhay K Varma; Arabinda Das; Gerald Wallace; John Barry; Alexey A Vertegel; Swapan K Ray; Naren L Banik
Journal:  Neurochem Res       Date:  2013-03-06       Impact factor: 3.996

Review 10.  Postmenopausal hormone replacement therapy: scientific review.

Authors:  Heidi D Nelson; Linda L Humphrey; Peggy Nygren; Steven M Teutsch; Janet D Allan
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.